CVA Family Office’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.2K | Buy |
202
+172
| +573% | +$37.6K | 0.01% | 566 |
|
|
2025
Q1 | $6.72K | Sell |
30
-36
| -55% | -$8.06K | ﹤0.01% | 861 |
|
|
2024
Q4 | $21.6K | Buy |
66
+54
| +450% | +$17.7K | ﹤0.01% | 662 |
|
|
2024
Q3 | $3.6K | Sell |
12
-12
| -50% | -$3.6K | ﹤0.01% | 893 |
|
|
2024
Q2 | $7.91K | Buy |
24
+3
| +14% | +$988 | ﹤0.01% | 772 |
|
|
2024
Q1 | $8.31K | Buy |
21
+1
| +5% | +$396 | ﹤0.01% | 768 |
|
|
2023
Q4 | $7.04K | Buy |
+20
| New | +$7.04K | ﹤0.01% | 772 |
|
|
2023
Q3 | – | Sell |
-25
| Closed | -$9.56K | – | 963 |
|
|
2023
Q2 | $9.56K | Buy |
25
+5
| +25% | +$1.91K | ﹤0.01% | 727 |
|
|
2023
Q1 | $6.93K | Buy |
+20
| New | +$6.93K | ﹤0.01% | 734 |
|
|
2022
Q4 | – | Sell |
-45
| Closed | -$11K | – | 1015 |
|
|
2022
Q3 | $11K | Sell |
45
-25
| -36% | -$6.11K | ﹤0.01% | 618 |
|
|
2022
Q2 | $21K | Buy |
70
+25
| +56% | +$7.5K | 0.01% | 535 |
|
|
2022
Q1 | $18K | Hold |
45
| – | – | ﹤0.01% | 589 |
|
|
2021
Q4 | $21K | Buy |
+45
| New | +$21K | 0.01% | 522 |
|
|
2021
Q3 | – | Sell |
-63
| Closed | -$23K | – | 894 |
|
|
2021
Q2 | $23K | Buy |
63
+18
| +40% | +$6.57K | 0.01% | 505 |
|
|
2021
Q1 | $13K | Buy |
+45
| New | +$13K | ﹤0.01% | 492 |
|